Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership955 shares
Latest Disclosed Value $ 426,456
HighPoint Advisor Group LLC reports 1.49% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR form disclosing ownership of 955 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $426,446 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 14, 2026 disclosing 941 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 1.49% during the quarter. The current value of the position is $409,065 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 955 14 1.49 426 0.00 0.0179
2026-05-14 2025-12-31 13F/A-2 VERTEX PHARMACEUTICALS Common Stock 92532F100 941 -3,563 -79.11 427 -75.84 0.0178
2026-02-04 2025-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 5,148 644 2,334 0.1082
2025-11-05 2025-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 4,504 467 11.57 1,764 -1.89 0.0840
2025-08-07 2025-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 4,037 26 0.65 1,797 -11.00 0.0955
2025-05-05 2025-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 4,011 406 11.26 2,020 23.03 0.1176
2025-02-12 2024-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,605 120 3.44 1,641 0.00 0.0892
2024-11-04 2024-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,485 -943 -21.30 1,642 81,950.00 0.0957
2024-08-08 2024-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 4,428 506 12.90 2 100.00 0.1329
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,922 334 9.31 2 -99.93 0.1191
2024-03-26 2023-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 3,588 1,834 104.56 1,493 192.17 0.1069
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 1,754 1,754 511 0.0559
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 0 -1,100 -100.00 0 -100.00
2021-07-29 2021-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 1,100 1,100 222 0.0224
2020-11-06 2020-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 0 -2,508 -100.00 0 -100.00
2020-08-13 2020-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 2,508 103 4.28 718 10.63 0.1535
2020-05-01 2020-03-31 13F/A-2 VERTEX PHARMACEUTICALS Common Stock 92532F100 2,405 -790 -24.73 649 -13.12 0.1545
2020-04-27 2020-03-31 13F/A-1 VERTEX PHARMACEUTICALS Common Stock 92532F100 649 -1,756 2 0.0379
2020-04-27 2020-03-31 13F VERTEX PHARMACEUTICAL COM Common Stock 92532F100 3,195 0 747 153,377.0674
2020-02-13 2019-12-31 13F VERTEX PHARMACEUTICAL COM Common Stock 92532F100 3,195 3,195 32.85 747 15.10 0.1539
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 0 -5,041 -100.00 0 -100.00
2019-08-15 2019-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 5,041 0 0.00 858 0.00 0.2101
2019-05-08 2019-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 5,041 -56 -1.10 858 -9.87 0.2101
2019-02-20 2018-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 5,097 160 3.24 952 8.68 0.2522
2018-10-23 2018-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 4,937 0 0.00 876 1.39 0.2399
2018-08-20 2018-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 4,937 4,937 864 0.2332
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.